IRIS
FONTI, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.043
EU - Europa 450
AS - Asia 357
AF - Africa 42
OC - Oceania 1
Totale 1.893
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.021
SG - Singapore 200
IT - Italia 190
CN - Cina 137
IE - Irlanda 57
FI - Finlandia 45
UA - Ucraina 45
CI - Costa d'Avorio 42
NL - Olanda 32
SE - Svezia 27
DE - Germania 23
CA - Canada 22
GB - Regno Unito 14
VN - Vietnam 6
BE - Belgio 5
HK - Hong Kong 4
IN - India 4
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
FR - Francia 2
IR - Iran 2
IS - Islanda 2
AU - Australia 1
DK - Danimarca 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
KR - Corea 1
RS - Serbia 1
Totale 1.893
Salva come PNG Salva come JPEG
Città #
Chandler 212
Singapore 161
Millbury 60
Jacksonville 55
Naples 55
Princeton 47
Santa Clara 45
Boston 41
Ashburn 38
Nanjing 37
Amsterdam 32
Beijing 27
Woodbridge 27
Des Moines 24
Napoli 22
Ottawa 20
Wilmington 20
Dublin 15
Lawrence 13
Hebei 12
Nanchang 12
Tianjin 12
Milan 10
Changsha 8
Shenyang 8
Falls Church 7
Dong Ket 6
Kronberg 6
Dearborn 5
Norwalk 5
Seattle 5
Boardman 4
Courcelles 4
Jiaxing 4
Bratislava 3
Caserta 3
Giugliano in Campania 3
Hangzhou 3
Lappeenranta 3
Bacoli 2
Cava 2
Frattamaggiore 2
Hong Kong 2
Mashhad 2
Milazzo 2
Nocera Inferiore 2
Osimo 2
Portici 2
Reykjavik 2
San Francisco 2
Tolentino 2
Venezia 2
Washington 2
Zhengzhou 2
Ann Arbor 1
Arezzo 1
Avigliano 1
Belgrade 1
Bloomfield 1
Bologna 1
Brussels 1
Casoria 1
Castel Volturno 1
Changchun 1
Copenhagen 1
Denpasar 1
Edinburgh 1
Fairfield 1
Forlì 1
Genova 1
Helsinki 1
Indiana 1
Jinan 1
Kunming 1
Lanzhou 1
Los Angeles 1
Magdeburg 1
Mcallen 1
Melfi 1
Mestre 1
Monza 1
New York 1
Norwich 1
Orange 1
Palermo 1
Paris 1
Piemonte 1
Pohang 1
Pune 1
Redwood City 1
San Giorgio A Cremano 1
San Giorgio del Sannio 1
Sandston 1
Sarno 1
Seregno 1
Slough 1
Stockholm 1
Sydney 1
Tel Aviv 1
Tokyo 1
Totale 1.150
Salva come PNG Salva come JPEG
Nome #
2-deoxy-2[F-18] fluoro-D-GLUCOSE POSITRON EMISSION TOMOGRAPHY Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphoma 65
Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma 56
Washout of 99mTc-Sestamibi in predicting response to chemotherapy in patients with multiple myeloma. 48
Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins. 46
Functional imaging of multidrug resistance in breast cancer. 45
Functional imaging of multidrug resistant phenotype by 99mTc-MIBI scan in patients with multiple myeloma 44
Contrast enhanced multi-detector CT and MR findings of a well-differentiated pancreatic vipoma 44
2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography in primary extranodal lymphomas: treatment response evaluation and prognosis 44
Liposomal doxorubicin supercharge-containing front-line treatment in patients with advanced-stage diffuse large B-cell lymphoma or classical Hodgkin lymphoma: Preliminary results of a single-centre phase II study 43
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study 41
The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study 41
PET/CT in cancer research: from preclinical to clinical applications. 40
Multimodal imaging with 18F-FDG-PET/CT and 111In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma 40
Machine Learning and Texture Analysis of [18F]FDG PET/CT Images for the Prediction of Distant Metastases in Non-Small-Cell Lung Cancer Patients 40
Nuclear imaging in cancer theranostic 39
Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients 39
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcima 39
99mTc-MIBI in the evaluation of breast cancer biology 39
Heterogeneity of SSTR2 expression assessed by 68Ga-DOTATOC PET/CT using coefficient of variation in patients with neuroendocrine tumors 37
Bone scintigraphy and SPECT/CT in bisphosphonate-induced osteonecrosis of the jaw 36
Detection of leptomeningeal involvement by 18F-FDG-PET/CT in a patient with non-Hodgkin lymphoma 36
Heterogeneity of glycolytic phenotype determined by 18F-FDG PET/CT using coefficient of variation in patients with advanced non-small cell lung cancer 33
A Survey of surgical Pathology of the medistinum preliminary data from a multicenter study”. 32
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 32
Brain metastases unresponsive to immunotherapy detected by 18F-FDG-PET/CT in a patient with melanoma 32
18F-FDG-PET/CT in the evaluation of bone marrow infiltration in patients with multiple myeloma. 31
Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1) 30
Visual and volumetric parameters by 18F-FDG-PET/CT: a head to head comparison for the prediction of outcome in patients with multiple myeloma 30
18F-FDG-PET/CT, 99mTc-MIBI and MRI in the evaluation of patients with multiple myeloma 29
Evidence of brown fat activity in constitutional leanness. 29
Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors 29
Sestamibi and FDG-PET scans to support diagnosis of jaw osteonecrosis. 28
18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma 28
Metabolic tumor volume assessed by 18F-FDG-PET/CT for the prediction of outcome in patients with multiple myeloma 28
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 28
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 27
Gefitinib induction of in vivo detectable signals by Bcl-2/Bcl-xL modulation of inositol trisphosphate receptor type 3. 26
99mTc-MIBI uptake in Bcl-2 overexpressing non-Hodgkin's lymphoma patients during drug-induced apoptosis. 26
Evaluation of metabolic response with 18F-FDG PET-CT in patients with advanced or recurrent thymic epithelial tumors. 26
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. 25
99mTc-MIBI uptake in breast cancer cells during early phases of apoptosis induction with Staurosporine 25
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. 25
Imaging of immunotherapy response in non-small cell lung cancer: challenges and perspectives. 25
Preclinical imaging in targeted cancer therapies. 24
In vitro receptor imaging for characterization of human solid tumors. 23
F-18-FDG-PET/CT, 99mTC-MIBI and MRI in the evaluation of patients with multiple myeloma 23
Non-canonical role of PDK1 as a negative regulator of apoptosis through macromolecular complexes assembly at the ER-mitochondria interface in oncogene-driven NSCLC 23
Combined imaging with 18F-FDG-PET/CT and 111In-labeled Octreotide SPECT for evaluation of thymic epithelial tumors 22
Monitoring reversal of MET-mediated resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer using 3'-deoxy-3'-[18F]-fluorothymidine positron emission tomography 22
SPECT imaging of endoplasmic reticulum-mediated tumor response to gefitinib and erlotinib in lung cancer 21
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 21
PET/CT in radiation oncology 21
Preclinical imaging for targeting cancer immune evasion 21
Detection of focal myeloma lesions by technetium-99m-sestaMIBI scintigraphy. 20
Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells. 20
PET-based volumetric biomarkers for risk stratification of non-small cell lung cancer patients 19
Oncologia 18
Sorafenib in advanced iodine-refractory differentiated thyroid cancer: efficacy, safety and exploratory analysis of role of serum thyroglobulin and FDG-PET. 18
Molecular Imaging of drug resistance in cancer. 16
Metabolic Tumor Volume assessed by 18F-FDG-PET/CT in the evaluation of plasma cell mass and prediction of outcome in patients with multiple myeloma. 16
Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer 16
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography. 14
Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non-Small Cell Lung Cancer Detected by 18F-Fluorothymidine 14
A look into the future: the role of PSMA beyond prostate cancer 12
What molecular imaging of cancer patients can teach us about COVID-19 12
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors. 9
Coefficient of variation in metastatic lymph nodes determined by 18F-FDG PET/CT in patients with advanced NSCLC: combination with coefficient of variation in primary tumors 8
99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors 8
Measurement of P-glycoprotein expression in human neuroblastoma xenografts using in vitro quantitative autoradiography 7
Measurement of P-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay 7
Sentinel lymph node identification in breast cancer patients 6
Ig antibody levels to Helicobacter pylori and histology of antral gastritis and duodenal ulcer: What is the correlation? 4
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma 4
Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study 3
Carcinoide timico in paziente affetta da sindrome da neoplasie endocrine multiple di tipo 1 (MEN1): ruolo dello screening radiologico e medico-nucleare 2
Metastasis to the Sellar/Suprasellar Region in a Patient with Endometrial Carcinoma Detected by 18F-FDG PET/CT 2
Totale 2.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 13 8 4 0 12 12 28 22
2020/2021147 1 10 20 10 24 25 12 4 19 5 9 8
2021/2022346 7 1 7 1 7 9 6 7 48 14 88 151
2022/2023473 65 48 11 35 66 57 3 56 67 34 26 5
2023/2024359 16 42 39 23 23 15 19 71 14 13 57 27
2024/2025285 101 113 6 19 46 0 0 0 0 0 0 0
Totale 2.002